The FDA-approved smoking cessation pill, varenicline, is emerging as a pivotal tool in the fight against nicotine addiction, particularly among teens and young adults.Recent clinical trials have highlighted a remarkably effective approach to quitting vaping, with varenicline demonstrating a success rate more than three times higher than traditional methods when combined with behavioral counseling.